These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 19896742

  • 1. Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis.
    Liu X, Zhu X, Wang A, Fan H, Yuan H.
    Int J Cardiol; 2009 Nov 12; 137(3):282-8. PubMed ID: 19896742
    [Abstract] [Full Text] [Related]

  • 2. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
    Liu W, Li WM, Gao C, Sun NL.
    J Autoimmun; 2005 Dec 12; 25(4):258-63. PubMed ID: 16242301
    [Abstract] [Full Text] [Related]

  • 3. Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balance.
    Hasegawa H, Takano H, Zou Y, Qin Y, Hizukuri K, Odaka K, Toyozaki T, Komuro I.
    J Mol Cell Cardiol; 2005 Feb 12; 38(2):257-65. PubMed ID: 15698832
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
    Tachikawa H, Kodama M, Hui L, Yoshida T, Hayashi M, Abe S, Kashimura T, Kato K, Hanawa H, Watanabe K, Nakazawa M, Aizawa Y.
    J Cardiovasc Pharmacol; 2003 Jan 12; 41 Suppl 1():S105-10. PubMed ID: 12688405
    [Abstract] [Full Text] [Related]

  • 5. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis.
    Yang S, Li W, Liu W, Gao C, Zhou B, Li S, Li Y, Kong Y.
    Clin Immunol; 2006 Oct 12; 121(1):63-73. PubMed ID: 16904381
    [Abstract] [Full Text] [Related]

  • 6. [Immune state of Th1, Th2 and Th17 subpopulation in experimental autoimmune myocarditis].
    Han LN, Li TL, Zhang YJ, Yang TS, Ding Y, Guo SL.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Nov 12; 42(6):751-6. PubMed ID: 22332535
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway.
    Haga T, Suzuki J, Kosuge H, Ogawa M, Saiki H, Haraguchi G, Maejima Y, Isobe M, Uede T.
    J Mol Cell Cardiol; 2009 May 12; 46(5):719-27. PubMed ID: 19233196
    [Abstract] [Full Text] [Related]

  • 8. Hepatocyte growth factor ameliorates the progression of experimental autoimmune myocarditis: a potential role for induction of T helper 2 cytokines.
    Futamatsu H, Suzuki J, Mizuno S, Koga N, Adachi S, Kosuge H, Maejima Y, Hirao K, Nakamura T, Isobe M.
    Circ Res; 2005 Apr 29; 96(8):823-30. PubMed ID: 15774858
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats.
    Suzuki J, Ogawa M, Futamatsu H, Kosuge H, Tanaka H, Isobe M.
    J Mol Cell Cardiol; 2006 May 29; 40(5):688-95. PubMed ID: 16499924
    [Abstract] [Full Text] [Related]

  • 11. Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice.
    Zhang S, Liu X, Sun C, Yang J, Wang L, Liu J, Gong L, Jing Y.
    Inflammation; 2016 Apr 29; 39(2):678-86. PubMed ID: 26658748
    [Abstract] [Full Text] [Related]

  • 12. Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats.
    Li WM, Liu W, Gao C, Zhou BG.
    Immunol Cell Biol; 2006 Jun 29; 84(3):274-80. PubMed ID: 16509827
    [Abstract] [Full Text] [Related]

  • 13. Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis.
    Ohshima M, Yamahara K, Ishikane S, Harada K, Tsuda H, Otani K, Taguchi A, Miyazato M, Katsuragi S, Yoshimatsu J, Kodama M, Kangawa K, Ikeda T.
    J Mol Cell Cardiol; 2012 Sep 29; 53(3):420-8. PubMed ID: 22796574
    [Abstract] [Full Text] [Related]

  • 14. [IL-10 gene modification on immature dendritic cells induces antigen-specific tolerance in experimental autoimmune myocarditis].
    Li WM, Liu W, Gao C, Zhou BG, Wang Z, Zhang RH, Kong YH, Li Y, Han W, Gan RT, Xue HJ, Geng JQ, Yang SS, Shao Q, Zhang M.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug 29; 34(8):703-7. PubMed ID: 17081394
    [Abstract] [Full Text] [Related]

  • 15. The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditis.
    George J, Barshack I, Goldberg I, Keren P, Gazit A, Levitzki A, Keren G, Roth A.
    Exp Mol Pathol; 2004 Jun 29; 76(3):234-41. PubMed ID: 15126106
    [Abstract] [Full Text] [Related]

  • 16. [Effects of adenovirus-mediated gene transfer of ICOSIg fusion protein on experimental autoimmune myocarditis in Lewis rats].
    Li WM, Liu W, Zhang RH, Wang Z, Kong YH, Li Y, Yang SS, Shen JX, Yu JB, Fan Y, Xue JY, Geng JQ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan 29; 35(1):28-32. PubMed ID: 17386160
    [Abstract] [Full Text] [Related]

  • 17. Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy.
    Sukumaran V, Watanabe K, Veeraveedu PT, Thandavarayan RA, Gurusamy N, Ma M, Yamaguchi K, Suzuki K, Kodama M, Aizawa Y.
    Exp Biol Med (Maywood); 2010 Nov 29; 235(11):1338-46. PubMed ID: 20876084
    [Abstract] [Full Text] [Related]

  • 18. The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat.
    Pando R, Barshack I, Raz A, Luboshits G, Haklai R, Maysel-Auslender S, Kloog Y, Keren G, George J.
    Cardiovasc Pathol; 2010 Nov 29; 19(2):94-101. PubMed ID: 19144546
    [Abstract] [Full Text] [Related]

  • 19. Naloxone, an opiate receptor antagonist, ameliorates acute experimental autoimmune myocarditis by reducing cytotoxic activities.
    Kishimoto C, Okabe TA, Hattori M, Yuan Z.
    J Cardiovasc Pharmacol; 2008 Nov 29; 52(5):445-51. PubMed ID: 19033824
    [Abstract] [Full Text] [Related]

  • 20. HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation.
    Azuma RW, Suzuki J, Ogawa M, Futamatsu H, Koga N, Onai Y, Kosuge H, Isobe M.
    Cardiovasc Res; 2004 Dec 01; 64(3):412-20. PubMed ID: 15537494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.